215 related articles for article (PubMed ID: 3607725)
1. Prognostic significance of plasma cell morphology in multiple myeloma.
Carter A; Hocherman I; Linn S; Cohen Y; Tatarsky I
Cancer; 1987 Sep; 60(5):1060-5. PubMed ID: 3607725
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of plasma cell morphology in multiple myeloma.
Paule B; Quillard J; Bisson M; Kahn MF; Massias P
Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
[TBL] [Abstract][Full Text] [Related]
3. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Rajkumar SV; Fonseca R; Lacy MQ; Witzig TE; Therneau TM; Kyle RA; Litzow MR; Gertz MA; Greipp PR
J Clin Oncol; 1999 May; 17(5):1551-7. PubMed ID: 10334543
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma: significance of plasmablastic subtype in morphological classification.
Greipp PR; Raymond NM; Kyle RA; O'Fallon WM
Blood; 1985 Feb; 65(2):305-10. PubMed ID: 3967084
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bone marrow histology in multiple myeloma.
Subramanian R; Basu D; Dutta TK
Indian J Cancer; 2009; 46(1):40-5. PubMed ID: 19282565
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow morphology in multiple myeloma.
Kuriakose P; Das S; Mani A
Indian J Cancer; 1995 Sep; 32(3):100-3. PubMed ID: 8772808
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of morphological classification in multiple myeloma.
Murakami H; Nemoto K; Sawamura M; Tamura J; Matsushima T; Naruse T; Tsuchiya J; Sato S; Shiamano S; Shinonome S
Acta Haematol; 1992; 87(3):113-7. PubMed ID: 1642091
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell morphology in multiple myeloma and related disorders.
Ribourtout B; Zandecki M
Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
Pasqualetti P; Colantonio D; Casale R
Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
[TBL] [Abstract][Full Text] [Related]
11. [Utility of the examination of plasma-cell morphology in the study of multiple myeloma].
Moro MJ; Portero JA; Gascón A; Hernández JM; Ortega F; Jiménez R; Guerras L; Martínez M; Casanova F; Sanz MA
Sangre (Barc); 1992 Jun; 37(3):175-9. PubMed ID: 1440094
[TBL] [Abstract][Full Text] [Related]
12. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of morphology in multiple myeloma].
Al-Sahmani M; Trnavská I; Antošová M; Antošová L; Kissová J; Kaisarová B; Adam Z; Buliková A; Penka M; Hájek R
Klin Onkol; 2012; 25(2):103-9. PubMed ID: 22533884
[TBL] [Abstract][Full Text] [Related]
14. Plasma cell maturity as a predictor of prognosis in multiple myeloma.
Iriyama N; Miura K; Hatta Y; Uchino Y; Kurita D; Takahashi H; Sakagami H; Sakagami M; Kobayashi Y; Nakagawa M; Ohtake S; Iizuka Y; Takei M
Med Oncol; 2016 Aug; 33(8):87. PubMed ID: 27383407
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma.
Cavo M; Baccarani M; Gobbi M; Lipizer A; Tura S
Br J Haematol; 1983 Dec; 55(4):683-90. PubMed ID: 6671088
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
[TBL] [Abstract][Full Text] [Related]
17. Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology.
Goasguen JE; Zandecki M; Mathiot C; Scheiff JM; Bizet M; Ly-Sunnaram B; Grosbois B; Monconduit M; Michaux JL; Facon T
Leuk Res; 1999 Dec; 23(12):1133-40. PubMed ID: 10613359
[TBL] [Abstract][Full Text] [Related]
18. Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.
Chakraborty R; Muchtar E; Kumar SK; Buadi FK; Dingli D; Dispenzieri A; Hayman SR; Hogan WJ; Kapoor P; Lacy MQ; Leung N; Gertz MA
Leuk Lymphoma; 2017 Feb; 58(2):308-315. PubMed ID: 27390076
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of cellular morphology in multiple myeloma.
Fritz E; Ludwig H; Kundi M
Blood; 1984 May; 63(5):1072-9. PubMed ID: 6713092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]